Insights

Global Expansion Kamada has a strong global presence with 6 FDA-approved products sold in over 30 countries, indicating potential sales opportunities for expanding market reach and exploring new regions for growth.

Strategic Partnerships Recent partnerships with companies like Kedrion S.p.A. and AC Milan demonstrate Kamada's commitment to collaboration, offering avenues for joint ventures and strategic alliances to drive sales through shared resources and expertise.

Innovative Product Portfolio Kamada's focus on rare and serious conditions, along with products like the Hyper-immune IgG for COVID-19, presents sales opportunities in niche markets with high demand for specialized treatments and potential for significant revenue generation.

Talented Leadership Team Key appointments like hiring Nir Livneh as Vice President and General Counsel bring expertise to the company, creating opportunities for leveraging strong leadership to build customer relationships, foster trust, and drive sales growth.

Financial Stability With a funding of $60M and proven success in manufacturing and commercialization, Kamada's financial health positions it well to invest in sales strategies, marketing initiatives, and distribution channels to drive revenue growth and capitalize on market opportunities.

Similar companies to KAMADA

KAMADA Tech Stack

KAMADA uses 8 technology products and services including WordPress, MySQL, Font Awesome, and more. Explore KAMADA's tech stack below.

WordPress
Content Management System
MySQL
Database
Font Awesome
Font Scripts
jQuery Migrate
Javascript Libraries
Open Graph
Miscellaneous
X-XSS-Protection
Security
Nginx
Web Servers
FlexSlider
Widgets

Media & News

KAMADA's Email Address Formats

KAMADA uses at least 1 format(s):

KAMADA Email Formats	Example	Percentage
firstl@kamada.com	JohnD@kamada.com	86%
firstlast@kamada.com	JohnDoe@kamada.com	7%
f_last@kamada.com	J_Doe@kamada.com	4%
firstla@kamada.com	JohnDo@kamada.com	3%

Frequently Asked Questions

Where is KAMADA's headquarters located?

KAMADA's main headquarters is located at Holtzman 2 Rehovot, IL. The company has employees across 4 continents, including AsiaNorth AmericaEurope.

What is KAMADA's phone number?

You can contact KAMADA's main corporate office by phone at +972-8-940-6472. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is KAMADA's stock symbol?

KAMADA is a publicly traded company; the company's stock symbol is KMDA.

What is KAMADA's official website and social media links?

KAMADA's official website is kamada.com and has social profiles on LinkedIn.

What is KAMADA's SIC code NAICS code?

KAMADA's SIC code is 5099 - Durable Goods, Not Elsewhere Classified NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does KAMADA have currently?

As of April 2024, KAMADA has approximately 305 employees across 4 continents, including AsiaNorth AmericaEurope. Key team members include CEO: S. O.Chief Operating Officer: E. N.VP R&D And Site Director: E. S.. Explore KAMADA's employee directory with LeadIQ.

What industry does KAMADA belong to?

KAMADA operates in the Pharmaceutical Manufacturing industry.

What technology does KAMADA use?

KAMADA's tech stack includes WordPressMySQLFont AwesomejQuery MigrateOpen GraphX-XSS-ProtectionNginxFlexSlider.

What is KAMADA's email format?

KAMADA's email format typically follows the pattern of . Find more KAMADA email formats with LeadIQ.

How much funding has KAMADA raised to date?

As of April 2024, KAMADA has raised $60M in funding. The last funding round occurred on May 24, 2023.

When was KAMADA founded?

KAMADA was founded in 1990.

KAMADA

Pharmaceutical ManufacturingRehovot, Israel201-500 Employees

Kamada is a growing commercial-stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions.
The company is a leader in the specialty plasma-derived field focused on diseases with limited treatment alternatives, with 6 FDA-approved products selling in over 30 countries.
The company is advancing an innovative development pipeline targeting areas of significant unmet medical need.